Comment: Serotonin Syndrome Induced by Fluvoxamine and Mirtazapine

Abstract

Get full access to this article

View all access options for this article.

References

Demers

Malone

. Serotonin syndrome induced by fluvoxamine and mirtazapine. Ann Pharmacother 2001; 35: 1217–20.

Sternbach

. The serotonin syndrome. Am J Psychiatry 1991; 148: 705–13.

Whyte

. Serotonin syndrome (letter). Curr Ther 1999; 40: 6–7.

Benazzi

. Serotonin syndrome with mirtazapine—fluoxetine combination (letter). Int J Geriatr Psychiatry 1998; 13: 495–6.

Price

Waller

Wood

MacKay

. A comparison of the postmarketing safety of four selective serotonin reuptake inhibitors including the investigation of symptoms occurring on withdrawal. Br J Clin Pharmacol 1996; 42: 757–63.

Nisijima

Yoshino

Yui

Katoh

. Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome. Brain Res 2001; 890: 23–31.

Hoes

Zeijpveld

. Mirtazapine as treatment for serotonin syndrome (letter). Pharmacopsychiatry 1996; 29: 81.

Anttila

Rasanen

Leinonen

. Fluvoxamine augmentation increases serum mirtazapine concentrations three- to fourfold. Ann Pharmacother 2001; 35: 1221–3.